[Muscle relaxant and reversal practices and impact of reversal modalities on operating room and postoperative room duration - results of a Delphi study].
Pratiques de curarisation/décurarisation et impact des modalités de décurarisation sur les durées en salle opératoire et SSPI – résultats d’une enquête Delphi.
Agents de réversion
Chirurgie laproscopique
Laparoscopic surgery
Neostigmine
Neuromuscular block
Pharmacoeconomics
Reversal agents
Sugammadex
bloc neuromusculaire
Journal
Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
12
11
2020
revised:
24
06
2021
accepted:
19
07
2021
pubmed:
28
7
2021
medline:
24
2
2022
entrez:
27
7
2021
Statut:
ppublish
Résumé
The objectives of this Delphi study are to describe muscle relaxant and reversal practices in France and to seek a consensus on the impact of the reversal method on the time spent in the OR and PACU. A two-round Delphi survey was conducted on a panel of French anesthetists involved in colectomies, hysterectomies or bariatric surgery. The questionnaire was designed in collaboration with a scientific committee and was intended to assess neuromuscular blockade reversal techniques and their impact on time spent in the OR and PACU. The first round gathered data on practices and the second round sought a consensus for the time aspect. Overall, all participants (99%) monitored neuromuscular blockade, with a majority (82%) doing so continuously. Of the participants, 22% routinely used a reversal drug. The time saved in the OR or PACU with sugammadex varied between 1 and 43 minutes depending on the surgery and the neuromuscular blockade reversal method it was compared to. Although SFAR recommendations (French Society of Anesthesia & Intensive Care Medicine) were generally well followed, the use of neuromuscular blockade reversal drugs was observed to be not fully integrated into regular practice, despite the fact that more than half of patients were reported to have residual neuromuscular blockade post-surgery and that sugammadex is known to reduce time spent in the OR and PACU compared to other neuromuscular blockade reversal methods.
Identifiants
pubmed: 34314682
pii: S0003-4509(21)00097-3
doi: 10.1016/j.pharma.2021.07.003
pii:
doi:
Substances chimiques
Neuromuscular Nondepolarizing Agents
0
Pharmaceutical Preparations
0
gamma-Cyclodextrins
0
Neostigmine
3982TWQ96G
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
227-237Informations de copyright
Copyright © 2021. Published by Elsevier Masson SAS.